Parmax Pharma Ltd - 540359 - Shareholder Meeting / Postal Ballot-Scrutinizer"s Report
Parmax Pharma shareholders approved a preferential issue of 31.37 lakh equity shares and 21.45 lakh convertible warrants at the EGM. These issues are to persons belonging to the non-promoter category, potentially leading to significant dilution.
Jul 03 2026 12:40:36
Parmax Pharma Ltd - 540359 - Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of Association
Parmax Pharma has amended its Memorandum and Articles of Association, increasing the authorized share capital from Rs. 6 crore to Rs. 10 crore. This action, approved by shareholders, provides the company with greater flexibility to raise equity capital in the future.
Jul 02 2026 21:10:31
Parmax Pharma Ltd - 540359 - Shareholder Meeting / Postal Ballot-Scrutinizer"s Report
Parmax Pharma's EGM approved the issuance of 31.37 lakh equity shares and 21.45 lakh convertible warrants via preferential issue. This capital raise to non-promoter investors will enhance financial flexibility.
Jul 02 2026 21:04:40
Parmax Pharma Ltd - 540359 - Shareholder Meeting / Postal Ballot-Outcome of EGM
Parmax Pharma's EGM held on July 2, 2026, approved key resolutions including a preferential issue of 31.37 lakh equity shares and 21.45 lakh convertible warrants to non-promoters. The company also approved an increase in its authorized share capital and new Articles of Association.
Jul 02 2026 19:11:09
Parmax Pharma Ltd - 540359 - Corrigendum To The Notice Of (2Nd/2026-27) Extraordinary General Meeting Of The Company
Parmax Pharma announced a corrigendum to its EGM notice, reclassifying several warrant allottees to the Promoter/Promoter Group. This change triggers SEBI SAST regulations, mandating an open offer process, and is expected to consolidate promoter control.
Jun 23 2026 19:26:12
Parmax Pharma Ltd - 540359 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Pradeep Gosalia disposed of 300,000 equity shares of Parmax Pharma, decreasing his holding from 8.09% to 0.07%. The transaction was executed on June 18, 2026, via an off-market share purchase agreement.
Jun 23 2026 11:25:40
Read More